LCM
CABA icon

Lynx1 Capital Management’s Cabaletta Bio CABA Stock Holding History

Lynx1 Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-492,103
Closed -$3.68M – 19
2024
Q2 		$3.68M Sell
492,103
-1,590,870
-76% -$19.5M 1.33% 10
2024
Q1 		$35.5M Sell
2,082,973
-27,428
-1% -$589K 9.15% 5
2023
Q4 		$47.9M Buy
2,110,401
+4,401
+0.2% +$74K 18.84% 2
2023
Q3 		$32.1M Sell
2,106,000
-75,377
-3% -$1.03M 21.2% 1
2023
Q2 		$28.2M Sell
2,181,377
-273,250
-11% -$2.97M 18.45% 2
2023
Q1 		$20.3M Sell
2,454,627
-371,349
-13% -$3.48M 16.92% 2
2022
Q4 		$26.1M Buy
+2,825,976
New +$10.3M 22.61% 1

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Lynx1 Capital Management's CABA Position: Q3 2024 in Review

Lynx1 Capital Management sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 492,103 shares — an estimated $3.68M sold.

Lynx1 Capital Management first reported a position in CABA in Q4 2022 and held it in 7 quarters. The position peaked at $47.9M in Q4 2023. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Lynx1 Capital Management reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Lynx1 Capital Management sold 492,103 Cabaletta Bio shares in Q3 2024, an estimated $3.68M.
  • Lynx1 Capital Management first reported a position in Cabaletta Bio in Q4 2022 and held it in 7 quarters.
  • Lynx1 Capital Management's Cabaletta Bio position peaked at $47.9M in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Lynx1 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.